Jordi Gilberte
Fortuna: 157 269 $ al 31/07/2026
Fortuna: 157 269 $ al 31/07/2026
Mr. Jordi P.
Gilberte is a Chief Operations Officer & Executive Director at GENinCode Plc.
He is on the Board of Directors at GENinCode Plc, GEN inCode U.S., Inc. and GENinCode SLU.
Mr. Gilberte was previously employed as a Chief Executive Officer & Director by Ferrer inCode SL and a Chief Financial Officer & Director by Gendiag Exe SL.
He also served on the board at Gendiag SL.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
GENINCODE PLC 1,94 % | 31/12/2024 | 14.602.500 ( 1,94 % ) | 157 269 $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| GENINCODE PLC | Fundador | 06/09/2018 |
GENinCode SLU | Director/Miembro de la Junta | - |
GEN inCode U.S., Inc. | Director/Miembro de la Junta | - |
| Empresas | Cargo | Fin |
|---|---|---|
Ferrer inCode SL | Director Ejecutivo | 01/09/2018 |
Gendiag Exe SL
Gendiag Exe SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Director Financiero/CFO | 01/09/2018 |
Gendiag SL
Gendiag SL BiotechnologyHealth Technology Researches and develops bio technology products | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Gendiag SL
Gendiag SL BiotechnologyHealth Technology Researches and develops bio technology products | Health Technology |
GENinCode Plc
GENinCode Plc Packaged SoftwareTechnology Services Develops risk assessment and prediction solutions for cardiovascular disease, thrombosis and familial hypercholesterolemia | Technology Services |
Ferrer inCode SL | |
Gendiag Exe SL
Gendiag Exe SL BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
GENinCode SLU | |
GEN inCode U.S., Inc. |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.